We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current SBX market cap is 32.54M. The company's latest EPS is EUR -2.0321 and P/E is -2.98.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 0 | 5.47M | 9.06M | 8.67M | 4M |
| Operating Income | -13k | -743k | -13.39M | -25.8M | -11.8M |
| Net Income | -13k | -880k | -12.73M | -24.36M | -10.63M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 238k | 35.03M | 60.65M | 40.62M | 34.92M |
| Total Liabilities | 2k | 9.53M | 23.92M | 17.83M | 19.59M |
| Total Equity | 236k | 25.5M | 36.73M | 22.79M | 15.33M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | N/A | -1.26M | -5.14M | -7M | -2.92M |
| Investing | N/A | -1.13M | -3.06M | -68k | -733k |
| Financing | N/A | 8.25M | 5.42M | 4.83M | 2.78M |
| Market Cap | 32.54M |
| Price to Earnings Ratio | -2.98 |
| Price to Sales Ratio | 7.93 |
| Price to Cash Ratio | 356.47 |
| Price to Book Ratio | 2.07 |
| Dividend Yield | - |
| Shares Outstanding | 5.23M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.24 (3.86%) |
| Company Name | SynBiotic SE |
| Address |
barer str. 7 munich 80333 |
| Website | https://www.synbiotic.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
